426 related articles for article (PubMed ID: 8457657)
1. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
2. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
3. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
4. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
Raut S; Gaffney PJ
Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
[TBL] [Abstract][Full Text] [Related]
8. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
9. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
Matsuda M; Baba M; Morimoto K; Nakamikawa C
J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
[TBL] [Abstract][Full Text] [Related]
10. The study of fibrin polymerization with monoclonal antibodies.
Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
[TBL] [Abstract][Full Text] [Related]
13. Functional role of Bbeta-chain N-terminal fragment in the fibrin polymerization process.
Lugovskoy EV; Gritsenko PG; Kapustianenko LG; Kolesnikova IN; Chernishov VI; Komisarenko SV
FEBS J; 2007 Sep; 274(17):4540-9. PubMed ID: 17681017
[TBL] [Abstract][Full Text] [Related]
14. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
15. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of the formation of complexes between monomer fibrin and the inhibitor of its polymerization - fragment D].
Belitser VA; Pozdniakova TM; Vovk EV; Rybachuk VN
Biokhimiia; 1983 Jan; 48(1):125-31. PubMed ID: 6830911
[TBL] [Abstract][Full Text] [Related]
17. Adsorption of fibrinogen and fragment D of fibrinogen onto the insolubilized alpha-chain of fibrin.
Matthias FR
Thromb Haemost; 1979 Jun; 41(4):687-90. PubMed ID: 483242
[TBL] [Abstract][Full Text] [Related]
18. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo.
Lill H; Spannagl M; Trauner A; Schramm W; Schuller D; Ofenloch-Haehnle B; Draeger B; Naser W; Dessauer A
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):97-102. PubMed ID: 8457660
[TBL] [Abstract][Full Text] [Related]
19. Novel monoclonal antibody that recognizes new neoantigenic determinant of D-dimer.
Doh HJ; Song KS; Kang MS; Kim DS; Kim KA; Kang J; Jang Y; Chung KH
Thromb Res; 2006; 118(3):353-60. PubMed ID: 16139872
[TBL] [Abstract][Full Text] [Related]
20. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]